Skip to main

Gideon T. Dosunmu, MBBS, MPH

  • One star
  • One star
  • One star
  • One star
  • One half star

Rating: 4.8 out of 5 (75 ratings)

${headerImageAssetTitle}

Background

Gideon T. Dosunmu, MBBS, MPH, is a medical oncologist who specializes in treating gastrointestinal cancer. Dr. Dosunmu joined the clinical staff at Winship Cancer Institute as an attending physician in 2025. His practice is based at Winship Cancer Institute at Emory Midtown and Grady Memorial Hospital.

Dr. Dosunmu is an assistant professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine.

He earned his medical degree from Oba Okunade Sijuade College of Health Sciences at Igbinedion University in Nigeria and received his MPH from the University of Alabama at Birmingham. He completed his internal medicine residency at the University of South Alabama in Mobile and his hematology and oncology fellowship at the University of Chicago Medical Center.

Titles & Roles

  • Assistant Professor, Department of Hematology and Medical Oncology
    Emory University School of Medicine

Education & Training

Education

  • Fellowship, Hematology/Oncology, 2025
    University of Chicago Medical Center
  • Residency, Internal Medicine, 2022
    University of South Alabama College of Medicine
  • Internship, 2015
    General Hospital, Lagos-NIG
  • Medical Education, MBBS, 2013
    Igbinedion University

Board Certifications

  • Internal Medicine
    American Board of Internal Medicine, 2023
  • Hematology
    American Board of Internal Medicine,

Professional Memberships

  • American Society of Clinical Oncology
  • American Society of Hematology
  • American Association for Cancer Research

Research

Dr. Dosunmu’s research focuses on cancer risk and prevention, germline testing and biomarker development in early-onset gastrointestinal cancers. His work aims to improve risk identification and expand the use of precision oncology tools in routine care. He also has research experience in genetics and early cancer detection.

Publications

Title/Journal Authors Publication Date

Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.

Cancer

 M Oyenuga, S Goyal, LM Hannan, O Emiloju, GT Dosunmu, R Miao, O Gbolahan, M Russell, J Lin, JM Switchenko, OB Alese 08/15/2026

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.8
  • One star
  • One star
  • One star
  • One star
  • One half star
Provider showed concern
4.8
  • One star
  • One star
  • One star
  • One star
  • One half star
Provider explained things clearly
4.8
  • One star
  • One star
  • One star
  • One star
  • One half star
Provider discussed treatment options
4.8
  • One star
  • One star
  • One star
  • One star
  • One half star
Provider included you in decisions
4.8
  • One star
  • One star
  • One star
  • One star
  • One half star
Likelihood of recommending this provider